This year's Nobel Prize in Physiology or Medicine has been awarded to Yoshinori Ohsumi for the discovery of the molecular principles governing autophagy, an intracellular degradation pathway routed via lysosomes or vacuoles. It is a story of a simple yet insightful yeast genetic screen that revealed the inner circuitry of one of the most powerful quality-control pathways in cells.
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Autophagy, a lysosome-mediated intracellular degradation pathway, was discovered in the late 1950s. Cell biologists exploring the mammalian cell with then newly developed high-resolution transmission electron microscopic (TEM) techniques were the first to observe in cells lysosome-like membrane-bound structures that contained organelles like mitochondria. Later, those structures were called cytolysosomes and next autophagosomes. In 1963, the term autophagy was coined by Christian de Duve (for review see Eskelinen et al., 2011) . At that time, it was impossible to imagine how broad and significant the influence of autophagy would turn out to be in the future. Autophagy is today recognized as a major quality-control pathway and metabolic regulation system in the cell. In essence, autophagy proceeds when a selected part of the cytosol is engulfed by a double membrane, forming the socalled autophagosome, which later fuses with lysosomes, digestive organelles of the cell, where a number of catabolic enzymes facilitate the breakdown of the cargo, enabling recycling of the generated metabolites. Autophagy can be driven by unspecific metabolic stimuli, such as starvation, or by highly specific signals facilitating the removal of damaged or superfluous proteins or organelles, thereby serving cellular homeostasis needs. The road to the discovery of the molecular basis of autophagy by Yoshinori Ohusumi is a story about importance of basic science, long-term dedication, and persistence that yielded unprecedented discoveries with broad significance to biology and medicine. The Royal Swedish Academy of Sciences now recognizes this fascinating work by awarding the 2016 Nobel Prize in Medicine or Physiology to Yoshinori Ohsumi.
A historical context is needed to appreciate the significance of Ohsumi's remarkable work. From the 1950s to the 1980s, many groups had been observing the formation of vesicles that are able to deliver intracellular components to the lysosome (for review see Eskelinen et al., 2011) . By the 1970s, biochemical analysis of this morphological phenomena in mammalian cells revealed the link between decreased amino acid levels and the formation of the autophagosome. The biochemical and morphological properties of autophagy continued to fascinate a small group of cell biologists through the 1980s during which time the suppressive potency of individual amino acids was reported, inhibitors were discovered, and the intracellular pathways and organelles involved were further explored (Ohsumi, 2014) . At that time, there was no understanding of the molecular mechanisms underlying autophagy to begin to understand what proteins and lipids were required for autophagy in mammalian cells.
Ohsumi approached this problem by studying autophagy in yeast, in which the lysosome-like vacuoles are end points of the autophagy pathway. In the 1980s, the first secretory pathway mutants were discovered by cell biologists working in the model system Saccharomyces cerevisiae, and progress was being made in understanding transport to and from the vacuole. Ohsumi identified autophagic bodies in nitrogen-deprived yeast S. cerevisiae and was the first to report that nutrient deficiency induced autophagic degradation in yeast. A key point in his approach was the use of vacuolar protease inhibitors to allow for accumulation of intermediate autophagic bodies, the inner membrane-bound content of the double membrane autophagosome, inside the vacuole (Takeshige et al., 1992 ). Ohsumi's lab characterized these structures by TEM and determined which proteases were required for their degradation (Figure 1 ). This seminal observation established the system and facilitated the first genetic screen for yeast autophagy mutants that was carried out in proteinase-deficient yeast cells to enable detection of the short-lived autophagic bodies. The mutants isolated were originally called ''apg'' (autophagy) (Tsukada and Ohsumi, 1993) . Apg1-1 mutants were identified by their defect in accumulation of autophagic bodies, and the Ohsumi lab observed that they lost viability much faster under conditions of nutrient deprivation. A further viability screen then elegantly identified 75 mutants that fell into another 15 complementation groups. With this groundbreaking work, the Ohsumi lab identified the first autophagy genes and showed that there are at least 15 needed in yeast. Others were soon to follow, as similar approaches were ongoing in Thumm's lab in Germany, who identified three new genes called AUT (Thumm et al., 1994) , and in Klionsky's lab on the cytoplasm-to-vacuole (CVT) pathway (Harding et al., 1995) . The commonalities between the nutrient-sensitive autophagy and constitutive CVT pathways were discovered through analysis of the apg complementation groups (Scott et al., 1996) . By 2003, the number of autophagy genes required for survival Cell 167, December 1, 2016 ª 2016 Elsevier Inc. 1433
